Santhera Pharmaceuticals Holding AG

Swiss Stock Exchange:SANN.SW

Location

Market Cap

USD 198.08 M

Share Price

USD 15.39

Avg Daily Volume

35,045

Change (1 day)

2.61%

Change (1 year)

65.26%

Change (YTD)

0.74%

Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2024: -40.62%

Santhera Pharmaceuticals Holding AG EBITDA Margin is -40.62% for the year ending December 31, 2024, a -153.05% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2023 was 76.56%, a -112.23% change year over year.
  • Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2022 was -625.97%.
  • Santhera Pharmaceuticals Holding AG EBITDA Margin for the year ending December 31, 2020 was -356.00%, a 3,458.36% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin